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Rubral tremor or Holmes tremor is not unusual. Any
lesion that occurs within the cerebello-thalamocortical
circuit and the Guillain-Mollaret triangle may result in
rubral tremor [1–3], but the pathophysiologic mechanism
is still not clear. Recent reports revealed that thalamotomy,
pallidotomy, or deep brain stimulation are effective.
As for medical treatment, results have, as yet, not been
conclusive. Here, we present a case of rubral tremor
successfully controlled by a single high daily dose of an
anticholinergic drug that may provide another option for
pharmacotherapy.
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A 24-year-old male suffered from acute-onset right-sided hemiparesis, dysarthria, and ophthalmoplegia in
February 2001. Brain magnetic resonance imaging revealed a cavernous angioma with hemorrhage over
the left thalamus. Moreover, some rhythmic, coarse, low-frequency (2–3 Hz) oscillation over the right wrist
and elbow was noted 1 month later. Action tremor was more predominant than resting tremor. Rubral
tremor was diagnosed on the basis of the clinical presentation and tremography analysis. Rubral tremor is
not unusual, and pharmacotherapy is nearly always ineffective in clinical practice. Deep brain stimulation,
thalamotomy, and pallidotomy are all considered effective according to recent research. However, they are
either very expensive or invasive, and involve surgical risks. In our patient, we tried valproate, clonazepam,
and verapamil one after another, but all in vain. Finally, titration of trihexyphenidyl provided significant
benefit. The tremor was successfully controlled by a single high daily dose of trihexyphenidyl (38 mg)
without severe or uncomfortable side effects. Here, we report a case of successful monotherapy of rubral
tremor with high-dose trihexyphenidyl.
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CASE PRESENTATION
A 24-year-old right-handed male patient presented in
February 2001 with an acute-onset right-sided hemiparesis,
right-sided conjugated gazing palsy, and dysarthria. He
visited a hospital for help, where he was diagnosed as
having a mass lesion with intracranial hemorrhage. He
subsequently came to us for a second opinion and treatment
plan. Physical examination did not show a Kayser-Fleischer
ring. Neurologic examination was the same as that in
February 2001. There was neither trauma nor headache,
and there was no family history of tremor or specific
medication history. The hemiparesis and dysarthria
improved gradually to nearly normal. However, an
involuntary, rhythmic coarse oscillation over the right
wrist and elbow was noted 1 month later. The tremor was
relatively coarse and slow. Tremography showed a frequency
of 2–3 Hz with a relatively high amplitude (Figure 1).
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This was compatible with rubral tremor. Cranial magnetic
resonance imaging (MRI) revealed a cavernous angioma
with partial absorption of hematoma over the left thalamus
(mediodorsal nucleus, ventroposteromedial nucleus, and
centromedian nucleus of the thalamus) (Figure 2). However,
there was no obvious evidence of inferior olivary nuclear
hypertrophy [3] (Figure 3).
Although rubral tremor has always been resistant to
pharmacotherapy in general practice, we did not choose
effective forms of treatment such as deep brain stimulation
or thalamotomy because of the risks and costs involved.
We tried valproate, clonazepam, verapamil, and
trihexyphenidyl in succession. Although clonazepam
showed some effect, it did not totally eliminate the tremor.
Only the titration of trihexyphenidyl showed significant
benefit. The tremor was completely controlled by a single
high daily dose of trihexyphenidyl (38 mg/day) without
severe, intolerant anticholinergic side effects, such as dry
mouth, dry eyes, or urinary retention (Figure 4).
DISCUSSION
Rubral tremor was first described by Gordon Holmes, in
1904, as an oscillation of the fingers with a rotation at the
wrist and the elbow on the basis of observations of a patient
with an organic lesion in the rubrospinal tracts in the pons.
However, the red nucleus was never proven as the source of
the abnormal oscillations, and concomitant damage to the
cerebellothalamic and nigrostriatal fibers might also be an
Figure 1. There are two predominant frequencies on tremography:
3.5 Hz and 7.5 Hz.
Figure 3. There is no obvious evidence on the MRI scan of inferior
olivary nuclear hypertrophy.
Figure 2. Small lesion of mixed signal intensity with a hypodense ring
of increased signal on T1- and T2-weighted MRI scans (arrow), located
at the left thalamus (mediodorsal nucleus, ventroposteromedial nucleus,
and centromedian nucleus of thalamus). The lesion was discovered 1
month after the occurrence of intracranial hemorrhage.
Figure 4. Gradual titration of trihexyphenidyl resulted in successful
treatment of rubral tremor.
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element. Thus, the term “rubral tremor” has recently been
replaced by “Holmes’ tremor” [4]. It has been described as
a combination of rest and action tremors, with the latter
being more predominant in amplitude than rest, and the
frequency being relatively lower. It has been associated
with a variety of etiologies, such as structural lesions of
cerebral hemorrhage, ischemia, trauma, multiple sclerosis,
neoplasm, and radiation.
There are some reports that support these etiologies,
including “midbrain tremor after pontine hemorrhage” [5],
“post-traumatic rubral tremor with midbrain lesion” [6],
“post-ischemic Holmes’ tremor”, and “the relation of hypo-
metabolism of the contra-lateral hemisphere thalamus,
red nucleus, and cerebellar hemisphere, including the
dentate nucleus based on FDG and H215O PET studies” [7].
However, not only structural lesions but also metabolic
causes may result in rubral tremor. Some reports suggest
that neuroleptics and toluene might cause Holmes’ tremor
[8,9]. Others have reported “idiopathic Holmes’ tremor”
[10]. Any condition that affects the dentatorubroolivary
pathway or the cerebellothalamocortical circuit (Mollaret
triangle) could result in rubral tremor.
Recently, many surgical clinical trials have shown
the effectiveness of deep brain stimulation, thalamotomy,
and pallidotomy [4,8,11,12]; however, these operations
are prohibitively expensive in Taiwan (NTD$800,000).
Unfortunately, medical treatment has, thus far, been
ineffective in controlling rubral tremor. Only occasional
papers have suggested that clonazepam, levodopa,
propranolol, and anticholinergic agents might be effective;
however, some authors provided different and, at times,
opposing opinions [4,5,8,9]. More consistent conclusions
have not been reached until recently, and these were not
with monotherapy.
In our case, the tremor had two predominant frequencies
on tremography. One was 3.5 Hz and the other was 7.5 Hz.
The 3.5-Hz frequency was compatible with rubral tremor,
whereas the 7.5-Hz frequency could be explained by his
original essential tremor (Figure 1). The tremor was finally
completely controlled by a single high daily dose of
trihexyphenidyl (38 mg) without significant side effects.
The patient discontinued his medication because he
thought that his tremor had been cured, but the tremor
returned. Nonetheless, when he resumed taking his
medication, the tremor subsided. This clinical course may
explain that trihexyphenidyl relieves the tremor, but it may
not be the usual course. Its success might be due to the
patient’s younger age and consequent potential for
neuroplasticity. Moreover, this treatment was easier in
clinical practice, when compared with the costs and the side
effects of surgery.
Weng et al reported similar results in his study [13]. He
used single-photon emission computed tomography
(SPECT) imaging with [2-[[2-[[[3-(4-chlorophenyl)-8-
m e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t - 2 - y l ] m e t h y l ] ( 2 -
mercaptoethyl)amino]ethyl]amino]ethanethiola-to (3-)-N2,
N2',S2,S2',]oxo-[1R-(exo-exo)]-[99mTc]technetium ([99mTc]
TRODAT-1) to prove dopamine deficiency in the
contralateral basal system. The cholinergic system and
dopamine system worked as part of the basal ganglion
axis in motor balance. When cholinergic levels decrease,
the dopamine system may increase activity. This may
partially explain why an anticholinergic agent was effective
in our case.
CONCLUSIONS
Rubral tremor is a syndrome, not a disease. This may
explain why there are no consistent results  of
pharmacotherapy for this condition. Our success may
have several explanations. First, the pathophysiology of
Weng et al’s patient and ours was similar, hence the
response to anticholinergic agents. Second, our patient
was young and had a potential for neuroplasticity. Third,
he could tolerate the side effects, so he kept on improving.
Subsequent to this case, we used high-dose trihexyphenidyl
successfully in treating a young patient with rubral tremor
due to a tumor of the cerebellum. However, severe side
effects precluded the use of high doses of trihexyphenidyl
in earlier patients.
High doses of trihexyphenidyl seem to be effective in
treating rubral tremor in patients who can tolerate the side
effects and who have the potential for neuroplasticity.
This finding provides an opportunity to explore the
mechanism of the tremor as well as its pharmacotherapy.
Additional evidence-based, randomized, double-blind
studies should examine the relationship between the
etiology of rubral tremor and effective pharmacotherapy.
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